BMS-986224 - ≥98% , CAS No.2055200-88-7

CAS: 2055200-88-7 Cat. No.: B648552 Fórmula: C24H23ClN4O6 Peso molecular: 498.92 PubChem CID: 137106310
Disponible para pedir
CALIDAD & PUREZA ≥98%
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Talla
Alemania (EU)
USA*
Precio
Cantidad
5mg
B648552-5mg
Fabricado bajo pedido · 8–12 semanas
1.128,84€
10mg
B648552-10mg
Fabricado bajo pedido · 8–12 semanas
1.701,55€
Enter a quantity for the sizes you want to add.

Descripción general

BMS-986224 is a potent, selective and orally active APJ receptor agonist ( K d = 0.3 nM). BMS-986224 exhibits similar receptor binding and signaling profile to (Pyr 1 ) apelin-13. BMS-986224 has the potential for the research of heart failure

In Vitro

BMS-986224 fully inhibits forskolin-mediated cAMP production, with an EC 50 for human APJ of 0.02 nM. BMS-986224 (0-100 nM) fully stimulates β-arrestin recruitment, ERK phosphorylation, and APJ internalization in Chinese hamster ovary-K1 or HEK293 ZF cells. BMS-986224 is a potent and selective APJ receptor agonist that exhibits a similar signaling profile to (Pyr1) apelin-13. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

BMS-986224 (0.192 mg/kg or 3 mg/kg; SC infusion; daily;) in the RHR model increased stroke volume and cardiac output to levels seen in healthy animals but without preventing cardiac hypertrophy and fibrosis, effects differentiated from enalapril . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male Sprague-Dawley rats (renal hypertensive rat model) Dosage: 0.192 mg/kg or 3 mg/kg Administration: SC infusion; daily; Initiated 3 days before surgery and continued for 7 days after surgery Result: The achieved steady-state plasma concentrations during 10-day infusion were 102 and 2686 nmol/L at low dose and HD, respectively. At the low dose, BMS-986224 increased SV and CO without affecting other measured parameters, including the measured diastolic parameters, cardiac fibrosis, and heart weight in RHR.

Form:Solid

IC50& Target:Kd: 0.3 nM (APJ receptor)

Especificaciones

Especificaciones y pureza
≥98%
Mecanismos bioquímicos y fisiológicos
BMS-986224 is a potent, selective and orally active APJ receptor agonist ( K d = 0.3 nM). BMS-986224 exhibits similar receptor binding and signaling profile to (Pyr 1 ) apelin-13. BMS-986224 has the potential for the research of heart failure.
Condiciones de almacenamiento de almacenamiento
Store at -20°C
Enviado en
Ice chest + Ice pads
Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.
Pureza
≥98%
Nombres e identificadores
Isómeros SMILES
CCOCC1=C(C(=C(C(=O)N1)C2=NN=C(O2)CC3=NC=C(C=C3)Cl)O)C4=C(C=CC=C4OC)OC
PubChem CID
137106310
Peso molecular
498.92

Datos avanzados

Objetivos asociados (no humanos)
Aplnr Apelin receptor (201 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mecanismos de acción
Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Propiedades químicas y físicas
SolubilidadDMSO : 20.83 mg/mL (41.75 mM; ultrasonic and warming and heat to 60°C)
Calculadoras de soluciones
Reseñas

Reseñas de cliente

¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?

Recordármelo más tarde

¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.

¡Vaya! Las notificaciones están desactivadas.